Anemia and hemoglobinopathies

PubMed Free Full Text

Anemia in cancer

Canada

• Canadian Oncology Nursing Journal
  • Hemoglobin matters: Perioperative blood management for oncology patients [2021]

Europe

• European Society for Medical Oncology
  • Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines [2018]
  • Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO Clinical Practice Guidelines for use [2010]

• Supportive Care in Cancer
  • A European patient record study on diagnosis and treatment of chemotherapy-induced anaemia [2014]

Germany

• Anemia
  • Antianemic Treatment of Cancer Patients in German Routine Practice: Data from a Prospective Cohort Study—The Tumor Anemia Registry [2016]

• Supportive Care in Cancer
  • Anemia diagnosis and therapy in malignant diseases: implementation of guidelines-a representative study [2024]

Poland

• Oncology in Clinical Practice
  • Anaemia in cancer patients — Expert Group recommendations [2017]

Romania

• Memo
  • APPLY: A prospective observational study of clinical practice patterns of darbepoetin alfa use in patients with chemotherapy-induced anemia in Romania [2018]

Spain

• Sociedad Española de Oncología Médica
  • SEOM clinical guidelines for anaemia treatment in cancer patients (2020) [2021]

United Kingdom

• National Institute for Health and Care Excellence
  • Erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy (including review of TA142) [2014]

United States

• American Journal of Hematology
  • Diagnosis and treatment of cancer-related anemia [2014]

• American Society of Clinical Oncology
  • Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update [2019]
  • American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer [2010]

• Oncologist
  • The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions [2021]

{Related topics}

• Topic
  • Anemia